Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Large-scale discovery of candidate type VI secretion effectors with antibacterial activity

Alexander Martin Geller, David Zlotkin, View ORCID ProfileAsaf Levy
doi: https://doi.org/10.1101/2021.10.07.463556
Alexander Martin Geller
1Department of Plant Pathology and Microbiology, the Robert H. Smith Faculty of Food and Environment, the Hebrew University of Jerusalem, Rehovot, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Zlotkin
1Department of Plant Pathology and Microbiology, the Robert H. Smith Faculty of Food and Environment, the Hebrew University of Jerusalem, Rehovot, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asaf Levy
1Department of Plant Pathology and Microbiology, the Robert H. Smith Faculty of Food and Environment, the Hebrew University of Jerusalem, Rehovot, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Asaf Levy
  • For correspondence: alevy@mail.huji.ac.il
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Type VI secretion systems (T6SS) are common bacterial contractile injection systems that inject toxic “effector” proteins into neighboring cells. Effector discovery is generally done manually, and computational approaches used for effector discovery depend on genetic linkage to T6SS genes and/or sequence similarity to known effectors. We bioinformatically investigated T6SS in more than 11,832 genomes of Gram negative bacteria. We found that T6SS encoding bacteria are host-associated and pathogenic, enriched in specific human and plant tissues, while depleted in marine, soil, and engineered environments. Analysis of T6SS cores with C-terminal domains (“evolved” cores) showed “evolved” HCP are rare, overwhelmingly encoded in orphan operons, and are largely restricted to Escherichia. Using the wealth of data generated from our bioinformatic analysis, we developed two algorithms for large-scale discovery of T6SS effector proteins (T6Es). We experimentally validated ten putative antibacterial T6SS effector proteins and one cognate immunity gene from a diverse species. This study provides a systematic genomic perspective of the role of the T6SS in nature, a thorough analysis of T6E evolution and genomic properties, and discovery of a large number of candidate T6Es using new approaches.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • ↵* The authors contributed equally to this work

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted October 07, 2021.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Large-scale discovery of candidate type VI secretion effectors with antibacterial activity
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Large-scale discovery of candidate type VI secretion effectors with antibacterial activity
Alexander Martin Geller, David Zlotkin, Asaf Levy
bioRxiv 2021.10.07.463556; doi: https://doi.org/10.1101/2021.10.07.463556
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Large-scale discovery of candidate type VI secretion effectors with antibacterial activity
Alexander Martin Geller, David Zlotkin, Asaf Levy
bioRxiv 2021.10.07.463556; doi: https://doi.org/10.1101/2021.10.07.463556

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4105)
  • Biochemistry (8808)
  • Bioengineering (6509)
  • Bioinformatics (23446)
  • Biophysics (11784)
  • Cancer Biology (9199)
  • Cell Biology (13314)
  • Clinical Trials (138)
  • Developmental Biology (7430)
  • Ecology (11403)
  • Epidemiology (2066)
  • Evolutionary Biology (15143)
  • Genetics (10430)
  • Genomics (14036)
  • Immunology (9167)
  • Microbiology (22142)
  • Molecular Biology (8802)
  • Neuroscience (47539)
  • Paleontology (350)
  • Pathology (1427)
  • Pharmacology and Toxicology (2489)
  • Physiology (3729)
  • Plant Biology (8076)
  • Scientific Communication and Education (1437)
  • Synthetic Biology (2220)
  • Systems Biology (6036)
  • Zoology (1252)